Literature DB >> 18055329

Pseudomyxoma peritonei secondary to epithelial appendicular neoplasms. Experience in a non-specialised centre.

J Ruiz-Tovar1, V Morales Castiñeiras, D García Teruel, A Sanjuanbenito Dehesa, E Lobo Martínez, E Martínez Molina.   

Abstract

INTRODUCTION: Pseudomyxoma peritonei is an infrequent entity, defined by collections of gelatinous material in the abdomen and pelvis and mucinous implants on peritoneum, secondary to the rupture of a mucinous lesion, usually of ovarian or appendiceal origin.
MATERIALS AND METHODS: We present our experience of 11 cases (6 males and 5 females) diagnosed with pseudomyxoma peritonei secondary to epithelial appendicular neoplasms over 27 years. The mean age of the patients was 68 years. Clinical manifestations were abdominal distension (55%), right lower quadrant pain (45%) suggesting acute appendicitis and constitutional syndrome (36%). An abdominal mass was detected at physical examination in 4 patients. CT scan revealed a tumour in right iliac fossa in 4 patients, peritoneal enlargement in 1 and a liquid collection in 1. Preoperative diagnosis was acute abdomen in 5 patients, peritoneal carcinomatosis in 3 and undetermined abdominal mass in 3.
RESULTS: Surgical findings suggested pseudomyxoma peritonei in 8 patients and peritoneal carcinomatosis in 3. Appendicectomy was performed in 9 patients, and in 3 of them bilateral anexectomy was also performed. One patient underwent ileocaecal resection and another a right hemicolectomy. In all the cases, mucinous material was eliminated as much as possible. Pathology revealed mucinous cystoadenoma in 6 cases, mucinous cystoadenocarcinoma in 3 and epithelial hyperplasia in 2 patients. Median survival was 54 months, with a 5- year survival rate of 40%. The last case we treated was sent to a reference centre for the treatment of pseudomyxoma peritonei.
CONCLUSIONS: There is no consensus on the best treatment for pseudomyxoma peritonei. We recommend avoiding incomplete surgical resections in non-reference centres and submitting patients to a reference centre to undergo adequate treatment.

Entities:  

Mesh:

Year:  2007        PMID: 18055329     DOI: 10.1007/s12094-007-0131-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  7 in total

1.  Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.

Authors:  Elizabeth M Murphy; Rosemary Sexton; Brendan J Moran
Journal:  Dis Colon Rectum       Date:  2007-01       Impact factor: 4.585

2.  Are there curative options to peritoneal carcinomatosis?

Authors:  Paul H Sugarbaker
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.

Authors:  Thomas J Miner; Jinru Shia; David P Jaques; David S Klimstra; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

Review 4.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

Authors:  Paul H Sugarbaker
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

5.  Mucocele of the appendix.

Authors:  J Ruiz-Tovar; D García Teruel; V Morales Castiñeiras; A Sanjuanbenito Dehesa; P López Quindós; E Martínez Molina
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

6.  Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.

Authors:  Joseph Misdraji; Rhonda K Yantiss; Fiona M Graeme-Cook; Ulysses J Balis; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

Review 7.  Pseudomyxoma peritonei.

Authors:  F L Hinson; N S Ambrose
Journal:  Br J Surg       Date:  1998-10       Impact factor: 6.939

  7 in total
  1 in total

1.  Use of FDG/PET CT to diagnose malignancy as the cause of mucocele of the appendix.

Authors:  Nilendu C Purandare; Arun Gandhi; Ameya D Puranik; Archi Agrawal; Sneha Shah; Asawari Patil; Venkatesh Rangarajan
Journal:  Indian J Gastroenterol       Date:  2013-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.